Subacute inflammatory demyelinating polyradiculoneuropathy complicating relapsing Hodgkin lymphoma: another immune-related adverse event of the anti-PD1 therapy?-Reference-Cited by-同舟云学术

Subacute inflammatory demyelinating polyradiculoneuropathy complicating relapsing Hodgkin lymphoma: another immune-related adverse event of the anti-PD1 therapy?

Published:2018-07-22 Issue:2 Volume:60 Page:547-549
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Barp Andrea¹,Gilardin Laurent²³,Afanasiev Vadim⁴,Delorme Cécile¹⁴,Viala Karine¹⁴,Bernard Sophie²,Brice Pauline²,Psimaras Dimitri⁵,Lenglet Timothée¹⁵

Affiliation:

1. Département de Neurophysiologie, Hôpital de la Pitié-Salpêtrière, APHP, Paris, France;

2. Service d’Onco-Hématologie, Hôpital Saint-Louis, APHP, Paris, France;

3. Institut National de la Santé et de la Recherche Médicale (INSERM), Unité Mixte de Recherche en Santé (UMR S) 1138, Centre de Recherche des Cordeliers, Equipe Immunopathology and Therapeutic Immunointervention, Paris, France;

4. Centre d’Evaluation et Traitement des Neuropathies, Hôpital de la Pitié-Salpêtrière, APHP, Paris, France;

5. OncoNeuroTox group: Center for investigations of patients with neurological complications after cancer treatment, Hôpitaux universitaires Pitié-Salpêtrière-Charles Foix et Val-de-Grâce, Paris, France

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2018.1485912

Reference16 articles.

1. PD-1 and PD-1 ligands: from discovery to clinical application

2. Phase I Study of Pembrolizumab (MK-3475; Anti–PD-1 Monoclonal Antibody) in Patients with Advanced Solid Tumors

3. Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma

4. Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy

5. Neurological toxicities associated with immune-checkpoint inhibitors

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pembrolizumab;Reactions Weekly;2019-06

2. Peripheral nervous system involvement in lymphomas;Journal of the Peripheral Nervous System;2019-01-08

3. Neuromuscular complications of immune checkpoint inhibitors;La Presse Médicale;2018-11